發(fā)布時(shí)間：2018-01-16 09:05

  本文關(guān)鍵詞：補(bǔ)陽還五湯對急性脊髓損傷患者血清MBP含量影響的臨床研究　出處：《福建中醫(yī)藥大學(xué)》2017年碩士論文　論文類型：學(xué)位論文

  更多相關(guān)文章： 補(bǔ)陽還五湯 急性脊髓損傷 MBP 神經(jīng)功能

【摘要】：目的:應(yīng)用補(bǔ)陽還五湯于急性脊髓損傷患者術(shù)后,通過探究補(bǔ)陽還五湯對急性脊髓損傷患者術(shù)后血清中MBP含量影響,并結(jié)合對比患者ASIA感覺、運(yùn)動(dòng)評分及等級(jí)同步變化,進(jìn)一步探討補(bǔ)陽還五湯在血清中MBP含量與神經(jīng)功能改善狀況的關(guān)系,為急性脊髓損傷患者術(shù)后功能恢復(fù)尋找新的治療方案與臨床參考指標(biāo)。方法:將2015年3月至2016年5月期間河南省洛陽正骨醫(yī)院醫(yī)院脊柱外科收治的60例急性脊髓損傷患者以入院時(shí)間為序隨機(jī)分為試驗(yàn)組和對照組,所有納入研究對象入院后均在創(chuàng)傷72h內(nèi)于急診或亞急診下行切開復(fù)位減壓內(nèi)固定手術(shù)。術(shù)后所有受試者均給予脫水、激素、抗炎和神經(jīng)營養(yǎng)類藥物常規(guī)治療。試驗(yàn)組在上述常規(guī)治療基礎(chǔ)上自術(shù)后第一天起開始服用補(bǔ)陽還五湯,每日一劑,持續(xù)服用12周。所有受試者在院期間均進(jìn)行常規(guī)康復(fù)訓(xùn)練,術(shù)后4*5周出院后繼續(xù)堅(jiān)持相關(guān)康復(fù)治療。采用ASIA評分量表分別于術(shù)前、術(shù)后4周、術(shù)后12周對所有受試者的感覺運(yùn)動(dòng)功能及生活自理能力進(jìn)行評估,同期運(yùn)用酶聯(lián)免疫吸附法對受試者血清中MBP含量進(jìn)行測定。數(shù)據(jù)分析采用SPSS20.0統(tǒng)計(jì)數(shù)據(jù)軟件進(jìn)行,全部測定數(shù)據(jù)以均數(shù)±標(biāo)準(zhǔn)差(X±S)格式記錄;兩組的性別、年齡、損傷節(jié)段、病程、損傷程度均進(jìn)行差異性分析,采用t檢驗(yàn)和方差分析計(jì)量資料,采用秩和檢驗(yàn)對不符合正態(tài)分布的計(jì)量資料分析;采用X2檢驗(yàn)分析計(jì)數(shù)資料。P0.05示差異有統(tǒng)計(jì)學(xué)意義。結(jié)果:組內(nèi)比較:術(shù)后12與術(shù)前、術(shù)后4周ASIA感覺評分比較:實(shí)驗(yàn)組有統(tǒng)計(jì)學(xué)意義(P0.05),對照組無統(tǒng)計(jì)學(xué)意義(P0.05);術(shù)后12與術(shù)前、術(shù)后4周ASIA運(yùn)動(dòng)評分及血清中MBP含量比較:兩組均有統(tǒng)計(jì)學(xué)意義(P0.05)。術(shù)后4周與術(shù)前ASIA感覺評分比較:兩組均無統(tǒng)計(jì)學(xué)意義(P0.05);術(shù)后4周與術(shù)前ASIA運(yùn)動(dòng)評分及血清中MBP含量比較:兩組均有統(tǒng)計(jì)學(xué)意義(P0.05)。組間比較:術(shù)前的ASIA感覺運(yùn)動(dòng)評分及血清中MBP含量比較:兩組差異無統(tǒng)計(jì)學(xué)意義(P0.05),具有可比性。術(shù)后4周及術(shù)后12周患者ASIA感覺評分比較:兩組差異無統(tǒng)計(jì)學(xué)意義(P0.05),ASIA運(yùn)動(dòng)評分比較差異有統(tǒng)計(jì)學(xué)意義(P0.05);血清中MBP含量比較:術(shù)后4周兩組差異有統(tǒng)計(jì)學(xué)意義(P0.05),術(shù)后12周兩組差異性比較無統(tǒng)計(jì)學(xué)意義(P0.05)。兩組治療前與術(shù)后12周ASIA分級(jí)比較:兩組差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:1.補(bǔ)陽還五湯對急性脊髓損傷術(shù)后患者的感覺運(yùn)動(dòng)功能評分以及ASIA等級(jí)有改善作用。2.補(bǔ)陽還五湯的應(yīng)用可以在早期明顯降低患者血清中的MBP含量。3.早期血清中MBP含量的變化程度與急性脊髓損傷患者術(shù)后功能恢復(fù)程度有相關(guān)性。
[Abstract]:Objective: to investigate the effect of Buyang Huanwu decoction (BHD) on serum MBP content in patients with acute spinal cord injury (sci) after operation, and to compare patients' ASIA sensation. To explore the relationship between the content of MBP in serum and the improvement of nerve function in the serum of Buyang Huanwu decoction. To find a new treatment plan and clinical reference index for postoperative functional recovery of patients with acute spinal cord injury (Asci). Methods:. From March 2015 to May 2016, 60 patients with acute spinal cord injury admitted in Department of Spine surgery, Luoyang Zhenggu Hospital, Henan Province, were randomly divided into experimental group and control group. All subjects were treated with open reduction and decompression and internal fixation within 72 hours of trauma. All subjects were given dehydration and hormone after operation. Routine treatment of anti-inflammatory and neurotrophic drugs. On the basis of the above routine treatment, the experimental group began to take Buyang Huanwu decoction once a day from the first day after operation. All subjects received routine rehabilitation training during the hospital and continued to adhere to the related rehabilitation treatment after 4 weeks of discharge. The ASIA scale was used before operation and 4 weeks after the operation. Sensory motor function and self-care ability of all subjects were evaluated 12 weeks after operation. At the same time, the content of MBP in serum was determined by enzyme-linked immunosorbent assay (Elisa). The data were analyzed by SPSS20.0 statistical data software. All the measured data were recorded in the format of mean 鹵standard deviation X 鹵S; Sex, age, injury segment, course of disease and degree of injury were all analyzed. T test and variance analysis were used to measure the data, and rank sum test was used to analyze the non-normal distribution data. X2 test was used to analyze the counting data. P0.05 showed statistical significance. Results: intragroup comparison: postoperative 12 and preoperative. Comparison of ASIA sensory scores at 4 weeks after operation: the experimental group had statistical significance (P 0.05), while the control group had no statistical significance (P 0.05). Postoperative 12 and preoperative. Comparison of ASIA motor score and serum MBP content at 4 weeks after operation: there was significant difference between the two groups (P 0.05), and ASIA sensory score at 4 weeks after operation was not statistically significant in both groups (P < 0.05). P0.05; 4 weeks after operation compared with preoperative ASIA motor score and serum MBP content: there was significant difference between the two groups (P 0.05). Group comparison: preoperative ASIA sensory motor score and serum MBP content comparison: there was no significant difference between the two groups (P 0.05). Comparison of ASIA sensory scores at 4 weeks and 12 weeks after operation: there was no significant difference between the two groups (P 0.05). The difference of ASIA motor score was statistically significant (P 0.05). Comparison of serum MBP levels: there was a significant difference between the two groups at 4 weeks after operation (P 0.05). There was no significant difference between the two groups at 12 weeks after operation (P 0.05). Comparison of ASIA grading before treatment and 12 weeks after operation: the difference between the two groups was statistically significant (P 0.05). ... conclusion:. 1. Buyang Huanwu decoction can improve the sensory and motor function score and ASIA grade of patients after acute spinal cord injury .2.The application of Buyang Huanwu decoction can obviously reduce the MBP content in patients' serum at the early stage. The level of serum MBP was correlated with the degree of postoperative functional recovery in patients with acute spinal cord injury (Asci).
【學(xué)位授予單位】：福建中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R651.2

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孫祥耀;海涌;;脊髓損傷非手術(shù)治療的研究進(jìn)展[J];中國骨與關(guān)節(jié)雜志;2016年06期

2 王玉明;宮慧明;武永剛;馬科;李建軍;;脊髓損傷臨床研究的納入標(biāo)準(zhǔn)和倫理問題[J];中國康復(fù)理論與實(shí)踐;2016年02期

3 王濤麗;顧兵;李華南;張國福;張思;;急性脊髓損傷后的炎癥反應(yīng)及其抗炎治療[J];中國藥理學(xué)通報(bào);2015年04期

4 黃衛(wèi);李新志;盧國強(qiáng);韓慶斌;陳文瑤;;急性脊髓損傷的治療現(xiàn)狀和研究進(jìn)展[J];中外醫(yī)療;2015年03期

5 李森;伍亞民;;脊髓損傷細(xì)胞治療的研究進(jìn)展及展望[J];中國矯形外科雜志;2014年20期

6 張輝;袁治國;邵建軍;;斷肢再植后肢體缺血再灌注損傷模型大鼠與補(bǔ)陽還五湯的干預(yù)影響[J];中國組織工程研究;2014年36期

7 杜公文;杜怡斌;張輝;尹宗生;;血管內(nèi)皮祖細(xì)胞在脊髓損傷修復(fù)中的研究進(jìn)展[J];中國矯形外科雜志;2013年14期

8 楊蕾;劉興本;朱昒霆;徐曉明;鄭傳斐;周禹鑫;;經(jīng)顱磁刺激運(yùn)動(dòng)誘發(fā)電位對脊髓損傷的評價(jià)及法醫(yī)學(xué)意義[J];法醫(yī)學(xué)雜志;2013年03期

9 孫金川;房清敏;;神經(jīng)營養(yǎng)因子與脊髓損傷的研究進(jìn)展[J];濱州醫(yī)學(xué)院學(xué)報(bào);2013年02期

10 趙昌松;張強(qiáng);蔡娟;袁征;高崢嶸;權(quán)學(xué)民;陳小龍;;頸脊髓損傷血液動(dòng)力學(xué)變化[J];中國矯形外科雜志;2012年22期

相關(guān)博士學(xué)位論文 前1條

1 吳波;少突膠質(zhì)前體細(xì)胞移植治療大鼠脊髓損傷的實(shí)驗(yàn)研究[D];第三軍醫(yī)大學(xué);2009年

相關(guān)碩士學(xué)位論文 前2條

1 張亞;補(bǔ)陽還五湯治療急性脊髓損傷的臨床觀察[D];福建中醫(yī)藥大學(xué);2014年

2 毛星剛;大鼠脊髓損傷后血—脊髓屏障的變化及其與繼發(fā)性損傷關(guān)系的研究[D];第四軍醫(yī)大學(xué);2007年

，

本文編號(hào)：1432421